US4826860A
(en)
*
|
1987-03-16 |
1989-05-02 |
Warner-Lambert Company |
Substituted 2-aminobenzothiazoles and derivatives useful as cerebrovascular agents
|
FR2619713B1
(fr)
*
|
1987-08-25 |
1990-08-31 |
Rhone Poulenc Sante |
Application de l'amino-2 trifluoromethoxy-6 benzothiazole pour obtenir un medicament destine au traitement des troubles du sommeil et de la depression
|
FR2619712B1
(fr)
*
|
1987-08-25 |
1990-08-31 |
Rhone Poulenc Sante |
Application de l'amino-2 trifluoromethoxy-6 benzothiazole pour obtenir un medicament destine au traitement de la schizophrenie
|
US5236940A
(en)
*
|
1988-12-15 |
1993-08-17 |
Rhone-Poulenc Sante |
Pharmaceutical compositions, 2-benzothiazolamine derivatives, and their preparation
|
FR2640622B1
(fr)
*
|
1988-12-15 |
1991-03-22 |
Rhone Poulenc Sante |
Derives de l'imino-2 benzothiazoline, leurs procedes de preparation et les medicaments les contenant
|
FR2649701B2
(fr)
*
|
1988-12-15 |
1991-11-22 |
Rhone Poulenc Sante |
Derives d'imino-2 benzothiazoline, leurs procedes de preparation et les medicaments les contenant
|
FR2649705B2
(fr)
*
|
1989-07-13 |
1994-09-23 |
Rhone Poulenc Sante |
Medicaments a base de derives de la benzothiazolamine-2, nouveaux derives et leur preparation
|
ES2043070T3
(es)
*
|
1988-12-15 |
1993-12-16 |
Rhone Poulenc Sante |
Procedimiento para la preparacion de derivados de la benzotiazolamina-2.
|
US4980356A
(en)
*
|
1988-12-15 |
1990-12-25 |
Rhone-Poulenc Sante |
2-imino-6-polyfluoroalkoxybenzothiazole derivatives, and pharamaceutical compositions containing them and their treatment of medical conditions associated with the effects of glutamate
|
FR2649703B1
(fr)
*
|
1989-07-13 |
1991-11-22 |
Rhone Poulenc Sante |
Derives d'imino-2 polyfluoroalcoxy-6 benzothiazole, leurs procedes de preparation et les medicaments les contenant
|
FR2640623B1
(fr)
*
|
1988-12-15 |
1991-03-22 |
Rhone Poulenc Sante |
Derives de la benzothiazoline, leurs procedes de preparation et les medicaments les contenant
|
FR2640624B1
(fr)
*
|
1988-12-15 |
1994-08-12 |
Rhone Poulenc Sante |
Medicaments a base de derives de la benzothiazolamine-2, nouveaux derives et leur preparation
|
ATE102612T1
(de)
*
|
1989-07-13 |
1994-03-15 |
Rhone Poulenc Sante |
2-imino-3 heterocyclylamino-benzothiazoline, ihre herstellung und sie enthaltende arzneimittel.
|
FR2661910B1
(fr)
*
|
1990-05-11 |
1992-08-21 |
Rhone Poulenc Sante |
Derives d'imino-2 heterocyclylalkyl-3 benzothiazoline, leur preparation et les medicaments les contenant.
|
US5260297A
(en)
*
|
1989-07-13 |
1993-11-09 |
Rhone Poulenc Rorer, S.A. |
2-imino-3-alkylbenzothiazoline derivatives bearing a heterocyclic substituent on the alkyl group, their preparation and medicinal products containing them.
|
FR2649704B1
(fr)
*
|
1989-07-13 |
1991-11-22 |
Rhone Poulenc Sante |
Derives d'imino-2 ethyl-3 benzothiazoline, leurs procedes de preparation et les medicaments les contenant
|
FR2649702B1
(fr)
*
|
1989-07-13 |
1991-11-22 |
Rhone Poulenc Sante |
Derives d'alkylimino-2 benzothiazoline, leurs procedes de preparation et les medicaments les contenant
|
FR2662160B1
(fr)
*
|
1990-05-18 |
1992-07-24 |
Rhone Poulenc Sante |
Derives d'alkylthio-3 propyl-3 benzothiazoline leur preparation et les medicaments les contenant.
|
FR2662694A1
(fr)
*
|
1990-06-05 |
1991-12-06 |
Rhone Poulenc Sante |
Derives du benzoselenazole, leur preparation et les medicaments les contenant.
|
FR2662695A1
(fr)
*
|
1990-06-05 |
1991-12-06 |
Rhone Poulenc Sante |
Amino-2 polyfluoroalcoxy-6 benzoselenazoles, leur preparation et les medicaments les contenant.
|
FR2663030A1
(fr)
*
|
1990-06-05 |
1991-12-13 |
Rhone Poulenc Sante |
Derives selenies de benzothiazoline leur preparation et les medicaments les contenant.
|
FR2663029B1
(fr)
*
|
1990-06-07 |
1992-07-31 |
Rhone Poulenc Sante |
Derives de benzothiazole, leur preparation et les medicaments les contenant.
|
FR2688138B1
(fr)
*
|
1992-03-06 |
1995-05-05 |
Rhone Poulenc Rorer Sa |
Application de l'amino-2 trifluoromethoxy-6 benzothiazole pour obtenir un medicament destine au traitement de la sclerose laterale amyotrophique.
|
FR2699077B1
(fr)
*
|
1992-12-16 |
1995-01-13 |
Rhone Poulenc Rorer Sa |
Application d'anticonvulsivants dans le traitement de lésions neurologiques liées à des traumatismes.
|
FR2700117B1
(fr)
*
|
1993-01-07 |
1995-02-03 |
Rhone Poulenc Rorer Sa |
Application d'anticonvulsivants dans le traitement de la maladie de Parkinson et des syndromes parkinsoniens.
|
FR2700116B1
(fr)
*
|
1993-01-07 |
1995-02-03 |
Rhone Poulenc Rorer Sa |
Application d'anticonvulsivants comme radioprotecteurs.
|
FR2702148B1
(fr)
*
|
1993-03-05 |
1995-04-07 |
Rhone Poulenc Rorer Sa |
Application d'anticonvulsivants dans le traitement du neuro-sida.
|
FR2726271B1
(fr)
*
|
1994-10-26 |
1996-12-06 |
Rhone Poulenc Rorer Sa |
Derives de 6-polyfluoroalcoxy-2-aminobenzothiazole
|
FR2786101B1
(fr)
|
1998-11-24 |
2002-07-05 |
Aventis Laboratoire |
Utilisation de la nicergoline dans le traitement de la spasticite
|
FR2787028B1
(fr)
|
1998-12-15 |
2002-10-18 |
Aventis Pharma Sa |
Utilisation du riluzole dans le traitement des traumatismes acoustiques
|
EP1142584A4
(de)
*
|
1999-01-12 |
2003-04-16 |
Takeda Chemical Industries Ltd |
Zusammensetzungen zur behandlung häufigen harnlassens sowie harninkontinenz
|
EP1337271B1
(de)
*
|
2000-11-30 |
2004-11-03 |
Pfizer Products Inc. |
Kombination von gaba agonisten und sorbitol dehydrogenase inhibitoren
|
MXPA03004871A
(es)
|
2000-11-30 |
2003-08-19 |
Pfizer Prod Inc |
Combinacion de agonistas de gaba e inhibidores de aldosa-reductasa.
|
IL163666A0
(en)
|
2002-02-22 |
2005-12-18 |
New River Pharmaceuticals Inc |
Active agent delivery systems and methods for protecting and administering active agents
|
RU2005135454A
(ru)
*
|
2003-05-16 |
2006-06-27 |
Пфайзер Продактс Инк. (Us) |
Терапевтические комбинации атипичных нейролептиков с модуляторами гамк и/или противосудорожными препаратами
|
ES2515092T3
(es)
|
2003-12-11 |
2014-10-29 |
Sunovion Pharmaceuticals Inc. |
Combinación de un sedante y un modulador neurotransmisor y métodos de mejorar la calidad del sueño y de tratar la depresión
|
BRPI0507190A
(pt)
*
|
2004-01-29 |
2007-06-26 |
Pfizer Prod Inc |
combinação de moduladores do ácido gama-aminobutìrico e antagonistas de 5-ht1b receptores
|
EP2201963B1
(de)
*
|
2005-04-05 |
2016-01-27 |
Yale University |
Glutamatmodulationsmittel bei der Behandlung mentaler Störungen
|
US9629817B2
(en)
|
2005-08-25 |
2017-04-25 |
Steven Michael Weiss |
Reducing myocardial damage and the incidence of arrhythmia arising from loss, reduction or interruption in coronary blood flow
|
EP2258358A3
(de)
|
2005-08-26 |
2011-09-07 |
Braincells, Inc. |
Neurogenese mit Acetylcholinesterasehemmer
|
CA2620333A1
(en)
|
2005-08-26 |
2007-03-01 |
Braincells, Inc. |
Neurogenesis by muscarinic receptor modulation
|
EP1940389A2
(de)
|
2005-10-21 |
2008-07-09 |
Braincells, Inc. |
Modulation von neurogenese durch pde-hemmung
|
WO2007053596A1
(en)
|
2005-10-31 |
2007-05-10 |
Braincells, Inc. |
Gaba receptor mediated modulation of neurogenesis
|
US20100216734A1
(en)
|
2006-03-08 |
2010-08-26 |
Braincells, Inc. |
Modulation of neurogenesis by nootropic agents
|
WO2007104035A1
(en)
*
|
2006-03-08 |
2007-09-13 |
Braincells, Inc. |
Modulation of neurogenesis by nootropic agents
|
US20100009983A1
(en)
*
|
2006-05-09 |
2010-01-14 |
Braincells, Inc. |
5 ht receptor mediated neurogenesis
|
EP2026813A2
(de)
|
2006-05-09 |
2009-02-25 |
Braincells, Inc. |
5-ht-rezeptor-vermittelte neurogenese
|
CA2651813A1
(en)
|
2006-05-09 |
2007-11-22 |
Braincells, Inc. |
Neurogenesis by modulating angiotensin
|
EP2068872A1
(de)
*
|
2006-09-08 |
2009-06-17 |
Braincells, Inc. |
Kombinationen mit einem 4-acylaminopyridin-derivat
|
US20100184806A1
(en)
|
2006-09-19 |
2010-07-22 |
Braincells, Inc. |
Modulation of neurogenesis by ppar agents
|
AU2007299920A1
(en)
*
|
2006-09-19 |
2008-03-27 |
Braincells, Inc. |
PPAR Mediated Modulation of Neurogenesis
|
US20080108827A1
(en)
*
|
2006-10-25 |
2008-05-08 |
Padi Pratap R |
Process for preparing riluzole
|
HUE032743T2
(en)
|
2006-11-22 |
2017-10-30 |
Clinical Res Ass Llc |
A method for treating Down syndrome, fragilis X syndrome and autism
|
US20090167322A1
(en)
*
|
2007-12-28 |
2009-07-02 |
Erik Edmund Magnuson |
Systems and method for classifying a substance
|
ES2388827T3
(es)
*
|
2008-04-03 |
2012-10-19 |
F. Hoffmann-La Roche Ag |
Uso de variantes de IGF-I PEGiladas para el tratamiento de trastornos neuromusculares
|
US20100216805A1
(en)
|
2009-02-25 |
2010-08-26 |
Braincells, Inc. |
Modulation of neurogenesis using d-cycloserine combinations
|
EP2284161A1
(de)
|
2009-07-21 |
2011-02-16 |
Edmond Pharma S.R.L. |
Verfahren zur Herstellung von Riluzol
|
EP3616686B8
(de)
|
2014-11-21 |
2021-06-23 |
Biohaven Pharmaceutical Holding Company Ltd. |
Sublinguale formulierung von riluzol
|
EP3220890A1
(de)
*
|
2014-11-21 |
2017-09-27 |
Biohaven Pharmaceutical Holding Company Ltd. |
Sublinguale verabreichung von riluzol
|
CN108283000B
(zh)
|
2015-09-23 |
2021-04-13 |
凯瑞康宁生物工程(武汉)有限公司 |
γ-羟基丁酸的前药及其组合物和用途
|
TWI788307B
(zh)
|
2016-10-31 |
2023-01-01 |
美商艾歐凡斯生物治療公司 |
用於擴增腫瘤浸潤性淋巴細胞之工程化人造抗原呈現細胞
|
EP3565586A1
(de)
|
2017-01-06 |
2019-11-13 |
Iovance Biotherapeutics, Inc. |
Erweiterung von tumorinfiltrierenden lymphozyten mit kaliumkanalagonisten und therapeutische verwendungen davon
|
RU2725886C1
(ru)
*
|
2017-03-30 |
2020-07-07 |
ЭксДабл-Ю ЛЭБОРЕТРИЗ ИНК. |
Бициклические гетероарильные производные и их получение и применение
|
ES2947089T3
(es)
|
2018-09-30 |
2023-08-01 |
Xwpharma Ltd |
Compuestos como antagonistas del receptor histamínico 3 neuronal y usos de los mismos
|
CA3162919A1
(en)
|
2019-12-20 |
2021-06-24 |
XWPharma Ltd. |
Methods of synthesizing 4-valyloxybutyric acid
|
CA3182394A1
(en)
|
2020-06-18 |
2021-12-23 |
Sami Karaborni |
Controlled release granulations of water-soluble active pharmaceutical ingredients
|
KR20230008190A
(ko)
|
2020-06-18 |
2023-01-13 |
엑스더블유파마 리미티드 |
수용성 원료의약품의 약학적 과립화제
|
WO2022020621A1
(en)
|
2020-07-24 |
2022-01-27 |
XWPharma Ltd. |
Pharmaceutical compositions and pharmacokinetics of a gamma-hydroxybutyric acid derivative
|
CN115666527A
(zh)
|
2020-10-05 |
2023-01-31 |
凯瑞康宁生物工程有限公司 |
γ-羟基丁酸衍生物的修饰释放组合物
|
JP2024511991A
(ja)
|
2021-03-19 |
2024-03-18 |
エックスダブリューファーマ リミテッド |
ガンマ-ヒドロキシ酪酸誘導体の組み合わされた放出製剤の薬物動態
|